Status:
COMPLETED
Mast-Cell Stabilizing Effects of Olopatadine
Lead Sponsor:
Alcon Research
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To assess the effects of olopatadine of the release of mast cell histamine
Eligibility Criteria
Inclusion
- Asymptomatic and not using any topical or systemic medication
Exclusion
- Age
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00389025
Start Date
October 1 2006
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Padova Site
Padua, Padova, Italy